siRNA干扰ATGL基因表达对猪脂肪细胞脂肪分解的抑制作用

【目的】探讨猪脂肪甘油三酯水解酶(adipose triglyceride lipase,ATGL)基因在脂肪细胞脂解中的作用。【方法】构建针对猪ATGL基因CDS区113和1 358位点的慢病毒干扰载体,包装后用其感染猪成熟脂肪细胞,检测ATGL和激素敏感脂酶(hormone-sensitive lipase,HSL)基因mRNA及其蛋白的表达情况;用甘油试剂盒检测细胞甘油释放量。【结果】成功构建了ATGL基因的慢病毒干扰载体,用其感染猪成熟脂肪细胞后,RT-PCR分析和Western印迹检测结果表明,试验组脂肪细胞ATGL的表达显著下调,HSL的表达没有明显变化;甘油释放量显著降低,其中针对ATGL基因CDS区113位点的siRNA1对ATGL mRNA的干扰效率达55%,甘油释放量降低了49%。【结论】成功构建了猪ATGL基因慢病毒干扰载体,其能显著降低ATGL基因mRNA及其蛋白在猪成熟脂肪细胞中的表达,降低脂肪细胞的甘油释放量,表明ATGL在猪脂肪细胞脂解中有着重要作用,且113位点是ATGL基因CDS区的最佳干扰靶位点。     

基于四环素调控系统构建白蛋白启动子调控大鼠uPA转基因表达的慢病毒载体

基于四环素调控系统构建白蛋白(albumin,Alb)启动子调控大鼠uPA(urokinase-type plasminogen activator,ruPA)转基因肝特异性过表达的慢病毒载体pLVX-Alb-TetOne-TRE-ruPA-T2A-CopGFP(pLATTRUTG)。以CTG0875-2-11质粒为模板,PCR扩增大鼠的uPA(ruPA)基因,3’端添加Flag标签,In-Fusion克隆至pLVX-Alb-TetOne-TRE-T2A-CopGFP(pLATTTG)质粒中,得到慢病毒载体pLVX-Alb-TetOne-TRE-ruPA-T2A-CopGFP(pLATTRUTG),所构建质粒经测序和酶切鉴定。将pLATTRUTG瞬时转染293T细胞,转染后24 h倒置荧光显微镜检测CopGFP表达;接着向6孔细胞培养板内加入强力霉素(Doxycycline,Dox),48 h后在倒置荧光显微镜下观察CopGFP表达(包括未加Dox的孔),随后收集细胞以提取总RNA和总蛋白,用于RT-qPCR检测ruPA及报告基因表达和Western blot检测标签蛋白Flag表达。酶切和测序确证我们成功构建了慢病毒载体pLATTRUTG;瞬转293T细胞后,24 h倒置荧光显微镜下可见零星细胞(约占0.1%)发弱的绿色荧光,加Dox 48 h后所有细胞展现强的绿色荧光,而不加Dox的孔内仍然只见到零星细胞(约占0.1%)发弱的绿色荧光。RT-qPCR和Western blot检测结果显示,与不加Dox的细胞相比,加Dox的细胞中ruPA、报告基因CopGFP和Flag表达水平显著升高。结果提示,成功基于四环素调控系统构建Alb启动子调控大鼠uPA转基因表达的慢病毒载体pLATTRUTG,为相关后续实验奠定了基础。     

One-cycle growth studies with Maedi—Progressive pneumonia—Visna viruses: Shorter latent periods revealed

The latent periods of Visna virus and of progressive pneumonia virus were demonstrated by one-cycle growth studies to end 14–16 hr after infection of sheep choroid plexus cell cultures. Maedi virus was demonstrated to have a 14–18-hr latent period.     

绵羊慢病毒自然感染绵羊的硬化性淋巴细胞性乳腺炎

７头来自新疆南部某绵羊慢病毒（ＯｖＬＶ）感染的羊场的绵羊用于本研究。用琼脂凝胶免疫扩散检查绵羊血清中对绵羊进行性肺炎（ＯＰＰ）病毒（ＯＰＰＶ）的抗体，结果表明有６例呈阳性，１例阴性，抗体效价在３年中呈下降趋势。４例血清学阳性边菜羊和１例阴性和田羊有不同程度的硬化性（纤维性）淋巴细胞性乳腺炎，小叶内有不等的淋巴细胞浸润，导管周围无淋巴滤泡形成，小叶间大量纤维组织增生。７例的肺、脑、关节、血管均无ＯｖＬＶ性特异性病变。从血清学阳性羊的外周血白细胞中未分离到ＯｖＬＶ。     

A survey of FIV antibodies and FeLV antigens in free-roaming cats in the capital area of Finland.

Feline immunodeficiency virus (FIV) was first isolated and identified in 1986. Since then it has been shown to have a worldwide distribution, and the infection generally appears to have reached a state of endemicity. This is the 1st study of FIV-prevalence in Finland. Serum samples of 196 free-roaming cats were tested for antibodies to FIV and FeLV antigens (Feline leukemia virus). With a combined enzyme-linked immunosorbent assay (ELISA), 13 of the cats (6.6%) turned out to be positive for FIV and 2 for FeLV (1.0%). Adult male cats in the capital area of Finland had a FIV prevalence of 24%, a relative proportion 4.7 times higher than that for females.     

Feline Immunodeficiency Virus and Puma Lentivirus in Florida panthers (Puma concolor coryi): Epidemiology and Diagnostic Issues

This study documents the seroprevalence of feline immunodeficiency virus (FIV) and puma lentivirus (PLV) in free-ranging and captive Florida panthers (Puma concolor coryi) (n = 51) and translocated Texas cougars (P. concolor stanleyana) (n = 10) from 1985 to 1998. The sera were tested for anti-FIV antibodies by enzyme-linked immunosorbent assay (ELISA) and Western blot tests. The ELISAs were read kinetically (KELA) and the sera were retrospectively examined by PLV peptide ELISA. Eleven panthers and one cougar were positive by KELA; 4 panthers and 4 cougars were equivocal; 35 panthers and 5 cougars were negative; and 1 panther had no data. Seven of the 11 KELA-positive panthers were also positive by Western blot tests and all but one were positive by PLV peptide ELISA. Ten KELA-negative and Western blot-negative cats, were positive by PLV peptide ELISA. KELA results varied within cats from one sample period to the next, but PLV peptide ELISA results were consistent. Territorial sympatry and mating behaviour, noted from radiotelemetry location data on the cats, may have contributed to viral transmission between seropositive animals. These findings suggest that Florida panthers and the introduced Texas cougars have been exposed to FIV and/or PLV.     

睾丸注射慢病毒生产转基因鸡的研究

【目的】采用睾丸注射慢病毒的方法生产转基因鸡以提高转基因效率,使转基因鸡的批量生产变得简单可行。【方法】用磷酸钙沉淀法包装慢病毒,对慢病毒包装体系中的质粒总量和HN Buffer的pH值进行优化,以包装出滴度较高的慢病毒;然后将慢病毒注射到受精鸡蛋的胚胎中验证其活性;最后,将慢病毒注射到8日龄公鸡的睾丸内,待其性成熟以后,将精液DNA呈阳性的公鸡与非转基因母鸡进行交配生产出转基因鸡。【结果】当90mm培养皿中质粒总量为50μg、HN Buffer的pH值为7.05时慢病毒的包装效率最高,在该条件下包装出的慢病毒滴度高达7.5×107 TU/mL;采用慢病毒胚胎注射途径成功地生产出增强绿色荧光蛋白(enhanced Green Fluorescent Protein,eGFP)转基因鸡;采用慢病毒睾丸注射途径生产的转基因鸡后代中能检测到eGFP目的基因,但未检测到其相关的表达。【结论】慢病毒睾丸注射途径能够将外源基因整合到精原干细胞中,并遗传给后代。     

表达抗流感病毒基因重组慢病毒滴度测定及感染效率分析

分别将靶向禽流感病毒(AIV)多靶点siRNA和鸡Mx基因克隆到p201慢病毒表达载体,采用鸡β-actin启动子替换p201慢病毒载体CMV启动子构建重组慢病毒载体p201-β-Mx-siRNA。并将其与辅助包装质粒共转染293T细胞,72h后收集细胞上清,实时荧光定量PCR测定重组慢病毒(rLV-MX-siR-NA)与对照组重组慢病毒(rLV-GFP)CT值,两者比较确定rLV-MX-siRNA滴度。rLV-Mx-siRNA以MOI=4感染猪胎儿成纤维细胞(PEF)并传代培养,提取后代细胞RNA检测外源基因转录以及应用间接免疫荧光试验检测鸡Mx蛋白的表达。结果表明,rLV-Mx-siRNA浓缩后滴度与已知滴度的rLV-GFP相等,为2×108 TU/mL,感染PEF效率>95%。感染rLV-Mx-siRNA的细胞传至第5代和第10代检测到外源基因转录以及鸡Mx蛋白的表达。表达鸡Mx基因和靶向AIV多靶点siRNA重组慢病毒滴度的测定与感染效率的分析,其结果为研究抗AIV转基因猪及其抗AIV的体外评价奠定了基础。